Evidence map›Paper›PMID 27586294›Full record

ArticleCurrent topics in membranes2016

Cardiac Sodium Channel Mutations: Why so Many Phenotypes?

M Liu, K-C Yang, S C Dudley

Open access · greenAbstract read
In one paragraph

Article in Current topics in membranes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Modulation of the cardiac sodium channel NaJournal of molecular and cellular cardiology · 2020
    Article
  7. Article
  8. Mutations in NaFrontiers in physiology · 2019
    Article
  9. IDENTIFYING NEW SUDDEN DEATH GENES.Transactions of the American Clinical and Climatological Association · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M LiuThe Warren Alpert Medical School of Brown University, Providence, RI, United States.
K-C YangThe Warren Alpert Medical School of Brown University, Providence, RI, United States.
S C DudleyThe Warren Alpert Medical School of Brown University, Providence, RI, United States.
Brown University · US

Funding

Na+ channel mRNA splicing in heart failureR01HL104025 · NHLBI · UNIVERSITY OF MINNESOTA · PI DUDLEY, SAMUEL C · 2011 to 2019
$3.3M
Unfolded Protein Response and ArrhythmiasR01HL134791 · NHLBI · UNIVERSITY OF MINNESOTA · PI DUDLEY, SAMUEL C · 2017 to 2020
$1.8M
Metabolic Regulation of Sodium ChannelsR01HL106592 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDLEY, SAMUEL C · 2011 to 2014
$1.6M
A blood test to predict sudden death riskR41HL112355 · NHLBI · ROS TECHNOLOGIES, INC. · PI DUDLEY, SAMUEL C · 2012 to 2012
$270k
American Heart Association-American Stroke Association 13POST14380029BLRD VA I01 BX000859NHLBI NIH HHS R01 HL104025NHLBI NIH HHS R01 HL106592NHLBI NIH HHS R01 HL134791NHLBI NIH HHS R41 HL112355
6 · The paper itself

Abstract

The cardiac Na(+) channel (Nav1.5) conducts a depolarizing inward Na(+) current that is responsible for the generation of the upstroke Phase 0 of the action potential. In heart tissue, changes in Na(+) currents can affect conduction velocity and impulse propagation. The cardiac Nav1.5 is also involved in determination of the action potential duration, since some channels may reopen during the plateau phase, generating a persistent or late inward current. Mutations of cardiac Nav1.5 can induce gain or loss of channel function because of an increased late current or a decrease of peak current, respectively. Gain-of-function mutations cause Long QT syndrome type 3 and possibly atrial fibrillation, while loss-of-function channel mutations are associated with a wider variety of phenotypes, such as Brugada syndrome, cardiac conduction disease, dilated cardiomyopathy, and sick sinus node syndrome. The penetrance and phenotypes resulting from Nav1.5 mutations also vary with age, gender, body temperature, circadian rhythm, and between regions of the heart. This phenotypic variability makes it difficult to correlate genotype-phenotype. We propose that mutations are only one contributor to the phenotype and additional modifications on Nav1.5 lead to the phenotypic variability. Possible modifiers include other genetic variations and alterations in the life cycle of Nav1.5 such as gene transcription, RNA processing, translation, posttranslational modifications, trafficking, complex assembly, and degradation. In this chapter, we summarize potential modifiers of cardiac Nav1.5 that could help explain the clinically observed phenotypic variability. Consideration of these modifiers could help improve genotype-phenotype correlations and lead to new therapeutic strategies.

Indexed as

Action PotentialsArrhythmias, CardiacGenotypeHumansMutationMyocytes, CardiacNAV1.5 Voltage-Gated Sodium ChannelPhenotypeProtein IsoformsRNA, MessengerRNA SplicingTranscription FactorsNAV1.5 Voltage-Gated Sodium ChannelProtein IsoformsRNA, MessengerTranscription FactorsChannelopathiesGenetic and genomic backgroundGenotype–phenotype variabilityIon homeostasisPosttranslational modifiersTranscriptional modifiersTranslational modifiers

Identifiers

PMID27586294
PMCPMC8597931
OpenAlexW2523471842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.